设为首页
Donor killer immunoglobulin-like receptor genetics influences graft-versus-lymphoma responses
HLA-matched killer immunoglobulin-like receptor B/x donors improve progression-free survival
Killer immunoglobulin-like receptor B/x donors benefit non-Hodgkin lymphoma patients undergoing matched unrelated transplantation